AstraZeneca quarterly net profit rises 2% on strong cancer drug sales

Euronews reports that AstraZeneca's second-quarter profit climbed two percent, fueled by strong cancer drug sales. The Anglo-Swedish pharmaceutical giant exceeded expectations and maintained its full-year outlook.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton